Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Adopting and Demonstrating the Adaptation of Prevention Techniques for Persons at Highest Risk of Acquiring or Transmitting Human Immunodeficiency Virus (ADAPT2), Funding Opportunity Announcement (FOA) Number PS07-004, 19521-19522 [E7-7331]

Download as PDF Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices year, plans for the coming year, a budget request for the next grant year, with complete justification, and appropriate signatures, and be submitted using Form OPHS–1. A Financial Status Report (FSR) SF–269 is due 90 days after the close of each 12-month budget period. A copy of the form will be sent with the Notice of Grant Award. VII. Agency Contact(s) For Application Kits, submission of applications, and information on budget and business aspects of the application, please contact: WilDon Solutions, Office of Grants Management Operations Center, 1515 Wilson Boulevard, Third Floor Suite 310, Arlington, VA 22209 at 1–888–203–6161, e-mail OPHSgrantinfo@teamwildon.com, or fax 703–351–1138. Also contact Wildon Solutions with questions regarding programmatic information and/or requests for technical assistance in the preparation of the grant application. VIII. Other Information Not applicable. Dated: April 13, 2007. Wanda K. Jones, Deputy Assistant Secretary for Health (Women’s Health), Office of Public Health and Science. [FR Doc. E7–7371 Filed 4–17–07; 8:45 am] BILLING CODE 4150–33–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Blood Safety and Availability Department of Health and Human Services, Office of the Secretary. ACTION: Notice. pwalker on PROD1PC71 with NOTICES AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood Safety and Availability (ACBSA) will hold a meeting. The meeting will be open to the public on both Thursday, May 10 and Friday, May 11, 2007. DATES: The meeting will take place Thursday, May 10, 2007 and Friday, May 11, 2007 from 9 a.m. to 5 p.m. ADDRESSES: Georgetown University Conference Center, 3800 Reservoir Road, NW., Washington, DC 20057. FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive Secretary, Advisory Committee on Blood Safety and Availability, Office of Public Health and Science, Department of Health and Human Services, 1101 Wootton Parkway, Room 250, Rockville, MD VerDate Aug<31>2005 17:04 Apr 17, 2007 Jkt 211001 19521 20852, (240) 453–8803, FAX (240) 453– 8456, e-mail ACBSA@hhs.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES The ACBSA will receive updates on previous recommendations to include variant Creutzfeldt Jacob Disease (vCJD), Chagas, Transfusion Related Acute Lung Injury (TRALI) and West Nile Virus. Since the last meeting, the Committee’s Charter was modified and approved by Secretary Leavitt in October 2006 to include broad public health, ethical and legal issues related to transfusion and transplantation safety. In order to understand these areas of commonality, the main topic of this meeting will center on presentations and discussion of common concerns in transfusion and transplantation safety. The new charter permits the expansion of the Committee ex-officio members to include agencies other than those currently having a permanent exofficio seat. Representation from the Division of Organ Transplantation within the Health Resources and Services Administration (HRSA) and the Office of Cellular, Tissue, and Gene Therapy within the Food and Drug Administration (FDA) will be added as Committee ex-officio members. Public comment will be solicited on Thursday, May 10, at noon and Friday, May 11, before noon. Comments will be limited to five minutes per speaker. Anyone planning to comment is encouraged to contact the Executive Secretary at his/her earliest convenience. Those who wish to have printed material distributed to Advisory Committee members should submit thirty (30) copies to the Executive Secretary prior to close of business May 7, 2007. Likewise, those who wish to utilize electronic data projection to the Committee must submit their materials to the Executive Secretary prior to close of business May 7, 2007. Centers for Disease Control and Prevention SUPPLEMENTARY INFORMATION: Dated: April 13, 2007. Jerry A. Holmberg, Executive Secretary, Advisory Committee on Blood Safety and Availability. [FR Doc. E7–7340 Filed 4–17–07; 8:45 am] BILLING CODE 4150–41–P PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Adopting and Demonstrating the Adaptation of Prevention Techniques for Persons at Highest Risk of Acquiring or Transmitting Human Immunodeficiency Virus (ADAPT2), Funding Opportunity Announcement (FOA) Number PS07–004 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 8:30 a.m.–9 a.m., May 18, 2007 (Open). 9 a.m.–4 p.m., May 18, 2007 (Closed). Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th Street, Atlanta, GA 30361. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of a research application in response to FOA PS07–004, ‘‘Adopting and Demonstrating the Adaptation of Prevention Techniques for Persons at Highest Risk of Acquiring or Transmitting Human Immunodeficiency Virus (ADAPT2).’’ Contact Person For More Information: J. Felix Rogers, M.P.H., PhD, Scientific Review Administrator, Extramural Research Program Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS E05, Atlanta, GA 30333, telephone 404.639.6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\18APN1.SGM 18APN1 19522 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices Dated: April 10, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7331 Filed 4–13–07; 10:39 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel ‘‘Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 7),’’ Request for Application Number (RFA) DP07–002 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 12 p.m.–4 p.m., June 5, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications received in response to RFA DP07–002, ‘‘Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 7).’’ Contact Person for More Information: Sheree Marshall Williams, PhD, M.Sc., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS D72, Atlanta, GA 30333, telephone 404.639.4896. pwalker on PROD1PC71 with NOTICES The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2007. Elaine L. Baker Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7332 Filed 4–17–07; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 17:04 Apr 17, 2007 Jkt 211001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group (NCIPC/IRG) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meetings of the aforementioned committee: Times and Dates: 2 p.m.–5 p.m., May 14, 2007 (Closed). 2 p.m.–5 p.m., May 15, 2007 (Closed). 2 p.m.–5 p.m., May 16, 2007 (Closed). 2 p.m.–5 p.m., May 17, 2007 (Closed). 2 p.m.–5 p.m., May 18, 2007 (Closed). Place: The conference calls will originate at the Centers for Disease Control and Prevention, Vanderbilt Building, Koger Center, Atlanta, Georgia. Times and Dates: 9 a.m.–10 a.m., May 21, 2007 (Open). 10 a.m.–5 p.m., May 21, 2007 (Closed). 9 a.m.–3 p.m., May 22, 2007 (Closed). 3 p.m.–5 p.m., May 22, 2007 (Open). 5 p.m.–7 p.m., May 22, 2007 (Closed). 9 a.m.–5:30 p.m., May 23, 2007 (Closed). 9 a.m.–5 p.m., May 24, 2007 (Closed). Place: Sheraton Midtown Atlanta Hotel Colony Square, Atlanta, Georgia. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of individual research grant and cooperative agreement applications submitted in response to two Fiscal Year 2007 Requests for Applications related to the following individual research announcements: 07002, Family and Dyadic Focused Interventions to PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Prevent Intimate Partner Violence; 07003, Maximizing Protective Factors for Youth Violence; 07004, Abusive Head Trauma (AHT) Prevention; 07005, Understanding Bullying and Sexual Violence Perpetration and Factors Associated with Both Outcomes; 07006, Grants for Traumatic Injury Biomechanics Research; 07007, Dissemination Research on Fall Prevention: ‘‘Stepping On’’ in a U.S. Community Setting; and 07008, The Impact of Traumatic Brain Injury Among Incarcerated Persons. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jane Suen, PhD, NCIPC/IRG, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone 770/ 488–1240. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7339 Filed 4–17–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1080, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 72 FR 14578, dated March 28, 2007) is amended to reflect the reorganization of the Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the mission statements for the Coordinating Center for Infectious Diseases (CV) and the Office of the Director (CVA), and insert the following: E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 72, Number 74 (Wednesday, April 18, 2007)]
[Notices]
[Pages 19521-19522]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7331]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Adopting and Demonstrating the Adaptation of Prevention 
Techniques for Persons at Highest Risk of Acquiring or Transmitting 
Human Immunodeficiency Virus (ADAPT2), Funding Opportunity Announcement 
(FOA) Number PS07-004

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.
    Time and Date:
     8:30 a.m.-9 a.m., May 18, 2007 (Open).
     9 a.m.-4 p.m., May 18, 2007 (Closed).
    Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th 
Street, Atlanta, GA 30361.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of a research application in response to FOA 
PS07-004, ``Adopting and Demonstrating the Adaptation of Prevention 
Techniques for Persons at Highest Risk of Acquiring or Transmitting 
Human Immunodeficiency Virus (ADAPT2).''
    Contact Person For More Information: J. Felix Rogers, M.P.H., PhD, 
Scientific Review Administrator, Extramural Research Program Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS 
E05, Atlanta, GA 30333, telephone 404.639.6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.


[[Page 19522]]


    Dated: April 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-7331 Filed 4-13-07; 10:39 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.